1. Home
  2. HCKT vs EBS Comparison

HCKT vs EBS Comparison

Compare HCKT & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hackett Group Inc (The).

HCKT

Hackett Group Inc (The).

HOLD

Current Price

$10.35

Market Cap

285.1M

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$6.67

Market Cap

312.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCKT
EBS
Founded
1991
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
285.1M
312.8M
IPO Year
1998
2006

Fundamental Metrics

Financial Performance
Metric
HCKT
EBS
Price
$10.35
$6.67
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$17.00
$12.00
AVG Volume (30 Days)
164.3K
1.1M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
3.67%
N/A
EPS Growth
N/A
125.83
EPS
0.34
N/A
Revenue
$285,862,000.00
$742,900,000.00
Revenue This Year
$2.55
$1.29
Revenue Next Year
$5.07
N/A
P/E Ratio
$30.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.16
$4.36
52 Week High
$20.68
$14.06

Technical Indicators

Market Signals
Indicator
HCKT
EBS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
HCKT
EBS

About HCKT Hackett Group Inc (The).

The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: